You just read:

Alexza Pharmaceuticals Announces Interim Results from its Phase 2a Study of AZ-002 (Staccato® alprazolam) in Epilepsy Patients

News provided by

Alexza Pharmaceuticals, Inc.

Dec 21, 2015, 04:10 ET